Dangerous liaisons: the role of “danger” signals in the immune response to gene therapy
Open Access
- 15 August 2002
- journal article
- review article
- Published by American Society of Hematology in Blood
- Vol. 100 (4) , 1133-1140
- https://doi.org/10.1182/blood-2001-11-0067
Abstract
Recent studies in gene transfer suggest that the innate immune system plays a significant role in impeding gene therapy. In this review, we examine factors that might influence the recruitment and activation of the innate system in the context of gene therapy. We have adopted a novel model of immunology that contends that the immune system distinguishes not between self and nonself, but between what is dangerous and what is not dangerous. In taking this perspective, we provide an alternative and complementary insight into some of the failures and successes of current gene therapy protocols.Keywords
This publication has 113 references indexed in Scilit:
- Lentiviruses get specificBlood, 2002
- Muscle-Directed Gene Transfer and Transient Immune Suppression Result in Sustained Partial Correction of Canine Hemophilia B Caused by a Null MutationMolecular Therapy, 2001
- Current treatment practice in immunosuppressionExpert Opinion on Pharmacotherapy, 2000
- Germ-line selection ensures embryonic autoreactivity and a positive discrimination of self mediated by supraclonal mechanismsSeminars in Immunology, 2000
- The Immunological Synapse: A Molecular Machine Controlling T Cell ActivationScience, 1999
- Retroviral Vectors for Liver-directed Gene TherapySeminars in Liver Disease, 1999
- Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha.The Journal of Experimental Medicine, 1994
- Sequence of the Murine Factor VIII cDNAGenomics, 1993
- Stimulation of IFN-γ, TNF-α, and TNF-β secretion in IL-2-activated T cells: Costimulatory roles for LFA-1, LFA-2, CD44, and CD45 moleculesCellular Immunology, 1992
- Circulating human or canine factor IX from retrovirally transduced primary myoblasts and established myoblast cell lines grafted into murine skeletal muscleSomatic Cell and Molecular Genetics, 1992